Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Jan;48(1):116–120. doi: 10.1136/gut.48.1.116

A study of hepatitis C prevalence in healthcare workers in the West of Scotland

D Thorburn 1, D Dundas 1, E McCruden 1, S Cameron 1, D Goldberg 1, I Symington 1, A Kirk 1, P Mills 1
PMCID: PMC1728181  PMID: 11115832

Abstract

BACKGROUND AND AIMS—Whether healthcare workers have an increased prevalence of hepatitis C virus infection as a result of exposure to patient's blood and body fluids is controversial. This study assesses the prevalence of hepatitis C virus infection in healthcare workers, and its relation to the performance of exposure prone procedures and duration of occupational exposure, allowing an estimate to be made of the incidence of occupationally acquired hepatitis C infection among medical staff.
METHODS—In this anonymous retrospective cohort study, we estimated the prevalence of hepatitis C infection in 10 654 healthcare workers. ELISA-3 testing was performed on pools of five sera collected during immunisation against hepatitis B. Healthcare workers were arranged into five occupational groups, according to the degree of patient exposure, and three age bands (<30 years, 30-39 years, >40 years).
RESULTS—Prevalence of antibodies to hepatitis C was 0.28% (30/10 654), comparable in all occupational groups (p=0.34) and unrelated to duration of potential exposure. Assuming that all detected infections had been occupationally acquired, the maximum estimated risk of hepatitis C infection in exposure prone medical staff was low: 1.4% for surgeons and 1.0% for physicians over a 35 year professional career.
CONCLUSIONS—Hepatitis C infection is infrequent in healthcare workers in Glasgow. Those conducting exposure prone procedures do not seem to be at higher risk than other healthcare staff.


Keywords: hepatitis C virus; epidemiology; exposure prone procedures; healthcare worker

Full Text

The Full Text of this article is available as a PDF (139.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

Results of testing sera from 10 654 healthcare workers for antibodies to hepatitis C virus (HCV) by ELISA-3 in pools of five.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Camilleri A. E., Murray S., Imrie C. W. Needlestick injury in surgeons: what is the incidence? J R Coll Surg Edinb. 1991 Oct;36(5):317–318. [PubMed] [Google Scholar]
  2. Cooper B. W., Krusell A., Tilton R. C., Goodwin R., Levitz R. E. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol. 1992 Feb;13(2):82–85. doi: 10.1086/646477. [DOI] [PubMed] [Google Scholar]
  3. Dow B. C., Coote I., Munro H., McOmish F., Yap P. L., Simmonds P., Follett E. A. Confirmation of hepatitis C virus antibody in blood donors. J Med Virol. 1993 Nov;41(3):215–220. doi: 10.1002/jmv.1890410309. [DOI] [PubMed] [Google Scholar]
  4. Esteban J. I., Gómez J., Martell M., Cabot B., Quer J., Camps J., González A., Otero T., Moya A., Esteban R. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med. 1996 Feb 29;334(9):555–560. doi: 10.1056/NEJM199602293340902. [DOI] [PubMed] [Google Scholar]
  5. Frischer M., Leyland A., Cormack R., Goldberg D. J., Bloor M., Green S. T., Taylor A., Covell R., McKeganey N., Platt S. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland. Am J Epidemiol. 1993 Aug 1;138(3):170–181. doi: 10.1093/oxfordjournals.aje.a116843. [DOI] [PubMed] [Google Scholar]
  6. García Z., Taylor L., Ruano A., Pavón L., Ayerdis E., Luftig R. B., Visoná K. A. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development. J Med Virol. 1996 Jul;49(3):218–222. doi: 10.1002/(SICI)1096-9071(199607)49:3<218::AID-JMV10>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  7. Goldberg D., Cameron S., McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health. 1998 Jun;1(2):95–97. [PubMed] [Google Scholar]
  8. Grellier L., Brown D., Power J., Dusheiko G. Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977. J Viral Hepat. 1997;4(6):379–381. doi: 10.1046/j.1365-2893.1997.00074.x. [DOI] [PubMed] [Google Scholar]
  9. Hayashi J., Kishihara Y., Yamaji K., Yoshimura E., Kawakami Y., Akazawa K., Kashiwagi S. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol. 1995 May;90(5):794–799. [PubMed] [Google Scholar]
  10. Kiyosawa K., Sodeyama T., Tanaka E., Nakano Y., Furuta S., Nishioka K., Purcell R. H., Alter H. J. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med. 1991 Sep 1;115(5):367–369. doi: 10.7326/0003-4819-115-5-367. [DOI] [PubMed] [Google Scholar]
  11. Lanphear B. P., Linnemann C. C., Jr, Cannon C. G., DeRonde M. M., Pendy L., Kerley L. M. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol. 1994 Dec;15(12):745–750. doi: 10.1086/646851. [DOI] [PubMed] [Google Scholar]
  12. Liu P., Shi Z. X., Zhang Y. C., Xu Z. C., Shu H. S., Zhang X. Y. A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus. Transfusion. 1997 Jul;37(7):732–736. doi: 10.1046/j.1537-2995.1997.37797369450.x. [DOI] [PubMed] [Google Scholar]
  13. McOmish F., Chan S. W., Dow B. C., Gillon J., Frame W. D., Crawford R. J., Yap P. L., Follett E. A., Simmonds P. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993 Jan;33(1):7–13. doi: 10.1046/j.1537-2995.1993.33193142314.x. [DOI] [PubMed] [Google Scholar]
  14. Mitsui T., Iwano K., Masuko K., Yamazaki C., Okamoto H., Tsuda F., Tanaka T., Mishiro S. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology. 1992 Nov;16(5):1109–1114. [PubMed] [Google Scholar]
  15. Neal K. R., Dornan J., Irving W. L. Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals. Who is at risk? BMJ. 1997 Jan 18;314(7075):179–180. doi: 10.1136/bmj.314.7075.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Niederau C., Lange S., Heintges T., Erhardt A., Buschkamp M., Hürter D., Nawrocki M., Kruska L., Hensel F., Petry W. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998 Dec;28(6):1687–1695. doi: 10.1002/hep.510280632. [DOI] [PubMed] [Google Scholar]
  17. Panlilio A. L., Shapiro C. N., Schable C. A., Mendelson M. H., Montecalvo M. A., Kunches L. M., Perry S. W., 3rd, Edwards J. R., Srivastava P. U., Culver D. H. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am Coll Surg. 1995 Jan;180(1):16–24. [PubMed] [Google Scholar]
  18. Puro V., Petrosillo N., Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control. 1995 Oct;23(5):273–277. doi: 10.1016/0196-6553(95)90056-x. [DOI] [PubMed] [Google Scholar]
  19. Shapiro C. N., Tokars J. I., Chamberland M. E. Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. The American Academy of Orthopaedic Surgeons Serosurvey Study Committee. J Bone Joint Surg Am. 1996 Dec;78(12):1791–1800. doi: 10.2106/00004623-199612000-00001. [DOI] [PubMed] [Google Scholar]
  20. Thomas D. L., Factor S. H., Kelen G. D., Washington A. S., Taylor E., Jr, Quinn T. C. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med. 1993 Jul 26;153(14):1705–1712. [PubMed] [Google Scholar]
  21. Thomas D. L., Gruninger S. E., Siew C., Joy E. D., Quinn T. C. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med. 1996 Jan;100(1):41–45. doi: 10.1016/s0002-9343(96)90009-1. [DOI] [PubMed] [Google Scholar]
  22. Yazdanpanah Y., Boëlle P. Y., Carrat F., Guiguet M., Abiteboul D., Valleron A. J. Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France. J Hepatol. 1999 May;30(5):765–769. doi: 10.1016/s0168-8278(99)80126-3. [DOI] [PubMed] [Google Scholar]
  23. Zuckerman J., Clewley G., Griffiths P., Cockcroft A. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet. 1994 Jun 25;343(8913):1618–1620. doi: 10.1016/s0140-6736(94)93064-3. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES